GAB2 (Ab-623) Antibody

What is GAB2 protein and what cellular functions does it regulate?

GAB2 (GRB2 Associated Binding Protein 2) is a member of the GAB family of adapter proteins that contains a pleckstrin homology (PH) domain and binds SHP2 tyrosine phosphatase and GRB2 adapter protein . It functions as a critical adapter protein transmitting signals from various receptors including cytokine receptors, growth factor receptors, and T- and B-cell antigen receptors .

GAB2 mediates numerous cellular processes including:

• Cell proliferation and survival

• Cell migration and differentiation

• Activation of PI3-Kinase/Akt and MAPK signaling pathways

• Regulation of hematopoiesis

• Mast cell activation and degranulation

• Osteoclast differentiation through TNFRSF11A/RANK signaling

GAB2 is ubiquitously expressed with highest levels found in brain, kidney, lung, heart, testis, and ovary .

What is the specificity of the GAB2 (Ab-623) polyclonal antibody?

The GAB2 (Ab-623) polyclonal antibody specifically detects endogenous levels of GAB2 protein only when phosphorylated at tyrosine 643 (Y643) . The antibody was produced using a synthesized peptide derived from human GAB2 around the phosphorylation site of Tyr643 (amino acid range: 609-658) . Validation experiments typically include:

• Western blot analysis of lysates from Jurkat cells treated with interferon (2500U/ML for 30 minutes)

• Immunohistochemistry analysis of paraffin-embedded human brain tissue

• Control experiments using blocking phospho-peptides to demonstrate specificity

How should GAB2 (Ab-623) antibody be stored and handled for optimal results?

For optimal performance and stability of the GAB2 (Ab-623) antibody:

• Store at 4°C for short-term storage (days to weeks)

• For long-term storage, aliquot and store at -20°C

• Avoid repeated freeze-thaw cycles which can degrade antibody quality

• The antibody is supplied as a liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

What are the optimal conditions for using GAB2 (Ab-623) antibody in Western blot applications?

Based on published experimental protocols:

• Sample preparation:

  • Treat cells with appropriate stimuli that induce GAB2 phosphorylation (e.g., IFN at 2500U/ML for 30 minutes for Jurkat cells)

  • Lyse cells in buffer containing phosphatase inhibitors to preserve phosphorylation status

• Western blot parameters:

  • Use standard SDS-PAGE with 8-10% gels (GAB2 has an apparent molecular weight of 95 kDa on SDS-PAGE despite a predicted weight of 74.5 kDa)

  • Transfer proteins to nitrocellulose or PVDF membrane

  • Block with 5% BSA in TBST (not milk, which contains phosphatases)

  • Dilute antibody as recommended by manufacturer

• Validation controls:

  • Include unstimulated cells as negative controls

  • Use blocking peptides to confirm specificity

  • Consider including positive controls (e.g., Jurkat cells treated with IFN)

How can I use the GAB2 (Ab-623) antibody for studying phosphorylation-dependent signaling events?

The GAB2 (Ab-623) antibody can be valuable for studying signaling cascades because:

• Experimental approaches:

  • Time-course experiments to monitor Y643 phosphorylation after stimulation

  • Compare phosphorylation levels across different cell types or conditions

  • Combine with inhibitors of upstream kinases to map signaling pathways

  • Use in co-immunoprecipitation experiments to identify phosphorylation-dependent protein interactions

• Applications in signaling research:

  • Monitor GAB2 Y643 phosphorylation in response to cytokine stimulation (e.g., IL-2, IL-3)

  • Investigate cross-talk between receptor tyrosine kinase pathways

  • Examine the relationship between Y643 phosphorylation and other phosphorylation sites (such as S623)

  • Study the role of GAB2 phosphorylation in disease models like AML

How does phosphorylation at Y643 relate to other known phosphorylation sites on GAB2, particularly S623?

The relationship between different phosphorylation sites on GAB2 reveals complex regulation mechanisms:

• Tyrosine vs. serine phosphorylation:

  • Y643 is one of the tyrosine residues that can be phosphorylated on GAB2, serving as a binding site for signaling proteins

  • S623 is phosphorylated by ERK MAPK and is located between Y614 and Y643, which are binding sites for SHP-2

• Functional interplay:

  • ERK-mediated phosphorylation of S623 regulates GAB2's association with SHP-2

  • S623 phosphorylation decreases the association between GAB2 and SHP-2

  • This creates a negative feedback loop: ERK phosphorylates GAB2 on S623, which reduces SHP-2 binding and subsequently affects both ERK activation and STAT5 signaling

• Signaling consequences:

  • Cells expressing GAB2 S623A mutant (which cannot be phosphorylated at this site) show:

    • Increased association with SHP-2

    • Higher tyrosine phosphorylation of SHP-2

    • Transient increase in ERK phosphorylation

    • Dramatic reduction in STAT5 transcriptional activity

    • Reduced proliferative response to IL-2

What methodological approaches can resolve contradictions in GAB2 phosphorylation data?

Researchers investigating GAB2 phosphorylation may encounter conflicting results. Here are methodological approaches to resolve these contradictions:

• Technical considerations:

  • Use multiple antibodies targeting different epitopes to confirm findings

  • Employ both phospho-specific antibodies and pan-GAB2 antibodies

  • Confirm antibody specificity using phosphopeptide competition assays

  • Include GAB2 knockout/knockdown controls

  • Utilize phosphatase treatments to confirm phospho-specificity

• Experimental design strategies:

  • Perform detailed time-course analyses (phosphorylation events can be transient)

  • Compare different cell types (phosphorylation patterns may be cell-type specific)

  • Use both in vitro and in vivo phosphorylation assays

  • Employ mass spectrometry to identify and quantify all phosphorylation sites simultaneously

  • Generate phospho-mimetic (S/T→D/E) and phospho-deficient (S/T→A, Y→F) mutants

• Integration approaches:

  • Combine biochemical assays with functional readouts

  • Use computational modeling to integrate multiple phosphorylation events

  • Consider the stoichiometry of phosphorylation at different sites

  • Investigate phosphorylation in the context of protein complexes rather than isolated proteins

How can GAB2 (Ab-623) antibody be used in research on hematological malignancies, particularly AML?

The GAB2 (Ab-623) antibody can be valuable in studying the role of GAB2 in acute myeloid leukemia (AML) and other hematological malignancies:

• Research applications in AML:

  • Monitor GAB2 Y643 phosphorylation status in primary AML samples with FLT3-ITD mutations

  • Compare phosphorylation patterns between normal and leukemic hematopoietic progenitors

  • Evaluate changes in GAB2 phosphorylation in response to tyrosine kinase inhibitors

  • Correlate phosphorylation levels with disease progression or treatment response

• Mechanistic studies:

  • Investigate the role of GAB2 in FLT3-ITD signaling networks

  • Examine how GAB2 promotes AML aggressiveness and drug resistance

  • Study how GAB2 coordinates signaling from multiple receptor tyrosine kinases

  • Explore the GAB2/STAT5 axis in regulating genes like Axl and Gfra2

• Translational potential:

  • Use the antibody to evaluate GAB2 as a biomarker in AML patient samples

  • Screen for compounds that disrupt GAB2 signaling

  • Monitor treatment responses at the molecular level

  • Investigate GAB2 phosphorylation in TKI-resistant AML cases

What are the most common technical challenges when using phospho-specific antibodies like GAB2 (Ab-623) and how can they be addressed?

Phospho-specific antibodies present unique challenges:

• Preserving phosphorylation status:

  • Always include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in lysis buffers

  • Process samples quickly and keep them cold

  • For tissue samples, snap-freeze immediately after collection

  • Consider using phosphatase inhibitor cocktails optimized for tyrosine phosphorylation

• Specificity concerns:

  • Validate antibody using blocking peptides (phosphorylated vs. non-phosphorylated)

  • Test antibody reactivity in cells where the phosphorylation site is mutated

  • Use siRNA or CRISPR knockout of GAB2 as negative controls

  • Compare results with other phospho-specific antibodies if available

• Signal optimization:

  • Optimize stimulation conditions (e.g., type of stimulus, concentration, duration)

  • Test various blocking agents (BSA often works better than milk for phospho-antibodies)

  • Consider signal enhancement systems for low-abundance proteins

  • Ensure transfer conditions are optimized for high molecular weight proteins

How can GAB2 (Ab-623) antibody be integrated with other methodologies to study the dynamics of GAB2 phosphorylation?

To comprehensively study GAB2 phosphorylation dynamics:

• Complementary techniques:

  • Flow cytometry with phospho-specific antibodies for single-cell analysis

  • Proximity ligation assay (PLA) to detect protein-protein interactions dependent on Y643 phosphorylation

  • FRET-based biosensors to monitor real-time phosphorylation changes

  • Phospho-proteomics to identify all phosphorylation sites simultaneously

• Advanced microscopy applications:

  • Immunofluorescence to visualize subcellular localization of phosphorylated GAB2

  • Live-cell imaging with tagged GAB2 constructs to track translocation

  • Super-resolution microscopy to examine nano-scale organization of signaling complexes

  • FRAP (Fluorescence Recovery After Photobleaching) to study mobility of GAB2 complexes

• Integrative approaches:

  • Combine with ChIP-seq to correlate GAB2 phosphorylation with transcriptional changes

  • Use RNA-seq to identify genes regulated downstream of GAB2 phosphorylation (e.g., Axl and Gfra2)

  • Integrate with computational modeling to predict signaling outcomes

  • Perform mutagenesis studies comparing phospho-mimetic and phospho-deficient GAB2 mutants

How is GAB2 phosphorylation being investigated in the context of cancer therapeutic resistance?

Current research examines GAB2's role in therapeutic resistance:

• Mechanisms of resistance:

  • GAB2 may promote resistance to tyrosine kinase inhibitors in FLT3-ITD-positive AML

  • Phosphorylation status of GAB2 could serve as a biomarker for predicting treatment response

  • GAB2 might incorporate alternative receptor tyrosine kinases into signaling networks, allowing bypass of targeted inhibitors

• Methodological approaches:

  • Use GAB2 (Ab-623) antibody to monitor phosphorylation changes in resistant vs. sensitive cells

  • Perform phospho-proteomic profiling before and after development of resistance

  • Generate cell line models with GAB2 mutations at key phosphorylation sites

  • Combine GAB2 inhibition with standard therapies to overcome resistance

• Translational applications:

  • Screen for compounds that disrupt GAB2 phosphorylation or its interactions

  • Evaluate GAB2 phosphorylation status as a predictive biomarker

  • Develop strategies targeting GAB2 scaffolding functions

  • Explore combination therapies targeting both GAB2 and its effector pathways

What are the methodological advances in studying GAB2 in hematopoietic development and disease?

Recent methodological innovations have enhanced GAB2 research in hematopoiesis:

• Advanced genetic models:

  • Conditional Gab2 knockout mice allow tissue-specific and temporal control of deletion

  • Knock-in mice expressing phosphorylation site mutants (e.g., S623A) provide insights into site-specific functions

  • Patient-derived xenograft models with GAB2 modifications help evaluate therapeutic strategies

• Single-cell technologies:

  • Single-cell phospho-flow cytometry to examine GAB2 phosphorylation in rare cell populations

  • Single-cell RNA-seq to correlate GAB2 activity with transcriptional programs

  • CyTOF (mass cytometry) for high-dimensional analysis of multiple phosphorylation sites simultaneously

  • Spatial transcriptomics to examine GAB2 expression in tissue microenvironment

• Functional readouts:

  • Ex vivo expansion assays of hematopoietic stem/progenitor cells from Gab2-deficient mice

  • Colony-forming unit assays to assess progenitor cell function

  • Competitive transplantation experiments to evaluate long-term reconstitution potential

  • In vitro differentiation systems to study lineage commitment decisions

These methodological advances have revealed that Gab2-deficient hematopoietic progenitor cells show decreased proliferation and attenuated signal transduction in response to early-acting cytokines, particularly affecting the PI3K and MAPK pathways .